Atlas Trials

Single-arm Clinical Trial of TACE in Combination With Icaritin as Adjuvant Therapy After Surgery in Patients With Hepatocellular Carcinoma at High Risk of Recurrence

Clinical trial NCT06644937 · RECRUITING

Trial details

NCT number
NCT06644937
Sponsor
Zhujiang Hospital
Status
RECRUITING
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Hepatocellular Carcinoma (HCC)
Start date
2024-11-29
Primary completion
2026-10-31
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.